1. Directory
  2. Georgia
  3. Atlanta
  4. Odylia Therapeutics
EIN 82-2120760

Odylia Therapeutics

IRS 501(c) type
501(c)(3)
Num. employees
4
City
Atlanta
State
Georgia
Year formed
2017
Most recent tax filings
2023-12-01
NTEE code, primary
H00: Medical Research: General
Description
Odylia Therapeutics utilizes a unique, non-profit business model to accelerate the development of gene therapies from people with rare disease, changing the way treatments are brought from the lab to the clinic. The company is actively advancing drug development for rare diseases through its top three programs: rpgrip1 and ush1c gene therapy programs, and brydge solutions.
Total revenues
$570,773
2023
Total expenses
$867,236
2023
Total assets
$9,688,644
2023
Num. employees
4
2023

Program areas at Odylia Therapeutics

Advancing drug development for rare diseases. Odylia's top three programs are rpgrip1, ush1c, and brydge solutions.

Who funds Odylia Therapeutics

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Foundation Fighting Blindness (FFB)Research$868,961
Usher 2020Research for Prevention of Usher Syndrome Blindness.$193,089
RDH12 Fund for SightResearch Grant$50,000
...and 4 more grants received

Personnel at Odylia Therapeutics

NameTitleCompensation
Ashley WinslowChief Executive Officer and Cso$210,664
Chrissy HerrenHead of Finance
Heather Hart GreeneDirector of Development
Jenny KleinManager of Operations and Program Management
Susie TrotochaudSecretary$0

Financials for Odylia Therapeutics

RevenuesFYE 12/2023
Total grants, contributions, etc.$289,283
Program services$241,089
Investment income and dividends$40,401
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$570,773

Form 990s for Odylia Therapeutics

Fiscal year endingDate received by IRSFormPDF link
2023-122024-11-08990View PDF
2022-122023-11-02990View PDF
2021-122022-11-15990View PDF
2020-122021-11-11990View PDF
2019-122021-02-17990View PDF
...and 1 more Form 990
Data update history
January 20, 2025
Posted financials
Added Form 990 for fiscal year 2023
January 19, 2025
Received grants
Identified 4 new grant, including a grant for $868,961 from Foundation Fighting Blindness (FFB)
October 25, 2024
Updated personnel
Identified 3 new personnel
January 23, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 23, 2024
Updated personnel
Identified 3 new personnel
Nonprofit Types
Medical research organizationsResearch centersCharities
Issues
Science and technologyHealth
Characteristics
Conducts researchTax deductible donationsAccepts online donations
General information
Address
830 Glenwood Ave Se 510-323
Atlanta, GA 30316
Metro area
Atlanta-Sandy Springs-Alpharetta, GA
County
Fulton County, GA
Website URL
odylia.org/ 
Phone
(770) 842-9741
IRS details
EIN
82-2120760
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2017
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H00: Medical Research: General
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
Free account sign-up

Want updates when Odylia Therapeutics has new information, or want to find more organizations like Odylia Therapeutics?

Create free Cause IQ account
Cause IQ is a website that helps companies grow, maintain, and serve their nonprofit clients, and helps nonprofits find additional foundation funding. Our data and tools help professionals prospect for nonprofits, research opportunities, benchmark their clients, and enrich existing information.
Nonprofits
Product
Customers
About

© 2025 Nonprofit Metrics LLC
Terms of Service and Privacy Policy